10. Income Tax

Components of Income and Income Tax Expense

The components of income before income tax provision were as follows:

Year Ended December 31, 

(in thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

Domestic

$

62,923

$

65,774

$

91,018

Foreign

 

19,786

 

23,016

 

4,859

Income before income taxes

$

82,709

$

88,790

$

95,877

Income tax provision was as follows:

Year Ended December 31, 

(in thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

  ​ ​ ​

2023

Current

 

  ​

 

  ​

 

  ​

Federal

$

12,580

$

31,492

$

35,225

State

 

8,903

 

16,893

 

12,848

Foreign

 

6,448

 

5,798

 

1,399

Total current tax provision

$

27,931

$

54,183

$

49,472

Deferred

 

  ​

 

  ​

 

  ​

Federal

$

1,015

$

(16,154)

$

(17,694)

State

 

1,596

 

(4,451)

 

(6,806)

Foreign

 

1,517

 

(1,019)

 

(561)

Total deferred tax benefit

$

4,128

$

(21,624)

$

(25,061)

Income tax provision

$

32,059

$

32,559

$

24,411

Effective Income Tax Rate

As of January 1, 2025, the Company adopted new FASB guidance related to income tax disclosures on a prospective basis.  The following table reconciles the U.S. federal statutory income tax rate to the effective income tax rate for 2025 pursuant to the new guidance:

Year Ended December 31, 2025

  ​ ​ ​

$ Amount

  ​ ​ ​

%

Statutory federal tax rate

 

$

17,369

 

21.0

%

State taxes, net of federal income tax effect*

8,295

10.0

Foreign tax effects

 

Israel

 

Stock based compensation

1,462

1.8

Other

634

0.7

United Kingdom

1,203

1.5

Other foreign jurisdictions

2,432

2.9

Effect of cross border tax laws

Foreign derived intangible income

(5,784)

(7.0)

Other

(611)

(0.7)

Tax credits

US R&D tax credits

(5,627)

(6.8)

Nontaxable or nondeductible items

Nondeductible officers' compensation

4,188

5.1

Stock based compensation

6,156

7.4

Other

974

1.2

Changes in unrecognized tax benefits

986

1.2

Other

382

0.5

Effective tax rate

$

32,059

38.8

%

*State taxes in California, New York City, and New York state made up a majority of the tax effect in this category.

The table below presents the Company’s effective tax rate reconciliations for 2024 and 2023 consistent with historical period disclosures:

Year Ended December 31, 

  ​ ​ ​

2024

  ​ ​ ​

2023

Statutory federal tax rate

 

21.0

%

21.0

%

State taxes

 

10.0

5.1

Tax credits

 

(4.8)

(2.1)

Foreign tax effects

 

2.5

0.5

Non‑deductible items and other

 

0.4

0.4

Changes in tax reserves

 

(0.8)

Provision to return adjustment

 

(0.9)

1.7

Transaction costs

0.1

0.3

Global Intangible Low Tax Income

 

3.2

1.1

Foreign-Derived Intangible Income

(2.1)

(2.9)

Non-deductible officers' compensation

4.0

1.8

Stock-based compensation

 

3.1

(0.5)

Effective tax rate

 

36.5

%  

25.6

%  

The Company’s effective tax rates for the years ended December 31, 2025, 2024, and 2023 were generally higher than the U.S. federal statutory income tax rate primarily as a result of the impact of state tax effects and other permanent book-tax differences, including non-deductible executive compensation and stock-based compensation.

Income Taxes Paid

The FASB guidance mentioned above also requires Companies to enhance disclosures regarding cash tax payments made during the year.  For the year ended December 31, 2025, the Company paid income taxes, net of any refunds, by jurisdiction as follows:

Year Ended December 31, 

  ​ ​ ​

2025

US federal

$

35,751

US state & local

 

CA

3,868

NY

4,244

NYC

4,097

Other

4,505

Foreign

Israel

3,740

Other

4,693

Total

$

60,898

Income tax payments for the years ended December 31, 2024 and 2023, as historically disclosed in the Consolidated Statements of Cash Flows, were $41.9 million and $60.9 million, respectively.

Deferred Income Taxes

Deferred income taxes reflect the net tax effects of temporary differences between the carrying amount of assets and liabilities for financial reporting purposes and the amounts used for income tax reporting purposes. The following table details the components of deferred tax assets and liabilities as of December 31, 2025 and 2024:

As of December 31, 

(in thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

Deferred tax assets:

 

  ​

 

  ​

Allowance for doubtful accounts

$

1,729

$

1,762

Accrued expenses and other

 

2,601

 

4,295

Stock compensation

9,201

10,089

Capitalized costs

41,231

42,841

Lease liability

22,837

21,468

Net operating losses

 

1,932

 

2,873

Gross deferred tax assets

 

79,531

 

83,328

Valuation allowance

 

(575)

 

(636)

Net deferred tax assets

$

78,956

$

82,692

Deferred tax liabilities:

 

  ​

 

  ​

ROU asset

$

(17,332)

$

(15,771)

Purchased intangibles

(30,429)

(30,110)

Depreciation and amortization

 

(11,742)

 

(9,832)

Total deferred tax liabilities

 

(59,503)

 

(55,713)

Net deferred tax asset

$

19,453

$

26,979

The Company has generally not recorded a deferred tax liability for foreign withholding or other relevant taxes on the undistributed earnings from the Company’s international subsidiaries, as such earnings are considered to be indefinitely reinvested, with the exception of certain earnings connected to one of the Company’s international subsidiaries.

Under the Tax Cuts and Jobs Act of 2017, research and development costs were no longer immediately tax deductible and were required to be capitalized and amortized for U.S. tax purposes effective January 1, 2022. The mandatory capitalization requirement temporarily increases our deferred tax assets and cash tax liabilities.  On July 4, 2025, the One Big Beautiful Bill Act modified these rules to allow the acceleration of tax deductions of certain research and development costs historically capitalized. The Company intends to deduct current US research and development costs on an as-incurred basis and deduct any remaining legacy US research and development amortizable costs within the 2025 and 2026 tax years.  

On August 16, 2022, the U.S. government enacted the Inflation Reduction Act which, among other changes, imposes a 15% corporate alternative minimum tax (“CAMT”) and a 1% excise tax on stock repurchases. The CAMT is effective for tax years beginning after December 31, 2022, but the CAMT has not had an effect upon the Company through December 31, 2024. The excise tax on stock repurchases applies to stock repurchases occurring after December 31, 2022.

Tax Valuation Allowance

As of each reporting date, management considers new evidence, both positive and negative, that could impact management’s view with regard to the future realization of deferred tax assets. Based on this analysis, the Company has concluded that it is more likely than not that the Company will realize all of its deferred taxes assets, with limited exception. A valuation allowance is recorded on a small amount of tax loss carryforwards that are subject to specific usage limitations.

Net Operating Loss and Credit Carryforwards

As of December 31, 2025, the Company had a Federal net operating loss carryforward of approximately $4.8 million and a state net operating loss carryforward of approximately $5.9 million. In addition, the Company had loss carryforwards for various foreign countries where the Company has business operations of approximately $5.6 million. Federal net operating loss carryforwards can be used to offset taxable income in the future and begin to expire in 2029. Utilization of Federal net operating loss carryforwards may be subject to annual limitations due to the “change in ownership” provisions of the Internal Revenue Code of 1986 and similar state provisions. The Company’s net operating loss carryforwards are subject to the annual limitation under Section 382 of the Internal Revenue Code.

Uncertain Tax Positions

The Company and its subsidiaries file income tax returns with the Internal Revenue Service (“IRS”) in various state and international jurisdictions. The Company’s income tax returns are open to examination by federal and state authorities for the tax years ended December 31, 2022 and later. The Company is currently under examination by the IRS for the tax year ended December 31, 2023.

For uncertain tax positions, the Company uses a more-likely-than-not recognition threshold based on the technical merits of the tax position taken. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefits determined on a cumulative probability basis, which are more-likely-than-not to be realized upon ultimate settlement in the financial statements. The Company has unrecognized tax benefits, which are tax benefits related to uncertain tax positions which have been or will be reflected in income tax filings that have not been recognized in the financial statements due to potential adjustments by taxing authorities in the applicable jurisdictions.

The Company's unrecognized tax benefits, which include interest and penalties, were $5.0 million and $2.7 million as of December 31, 2025 and 2024, respectively. The amount of unrecognized tax benefits that, if recognized, would affect the Company's effective tax rate are $4.8 million and $2.2 million as of December 31, 2025 and 2024, respectively, and include the federal tax benefit of state deductions.

Changes in the Company’s unrecognized tax benefits were as follows:

Year Ended December 31, 

(in thousands)

  ​ ​ ​

2025

  ​ ​ ​

2024

Beginning balance

$

2,651

$

2,690

Increase related to tax positions of prior years

 

2,334

 

287

Increase related to tax positions of the current year

 

821

 

433

Decrease due to lapse in statutes of limitations

(829)

(759)

Ending balance

$

4,977

$

2,651

Free Sentinel

Want the next DoubleVerify Holdings, Inc. income taxes disclosure the moment it drops?

Set a Sentinel and we'll alert you the moment DoubleVerify Holdings, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.

Track for free

Historical Timeline

Fiscal YearFiled
2025Feb 26, 2026Showing above
2024Feb 27, 2025
2023Feb 28, 2024
2022Mar 1, 2023

About Income Taxes Disclosures

The income tax disclosure reveals how much a company actually pays in taxes versus what the statutory rate would predict. Analysts focus on the effective tax rate (ETR) reconciliation, which breaks down every item driving the gap between the 21% federal rate and the company's reported ETR — including R&D credits, foreign rate differentials, and state taxes. Deferred tax assets (DTAs) and their valuation allowances signal management's confidence in future profitability: a rising allowance suggests the company doubts it can use accumulated tax benefits. Uncertain tax benefit (UTB) reserves quantify exposure to IRS challenges on aggressive positions.

Key signals to watch: sudden ETR drops without clear operational reasons, large increases in valuation allowances, growing UTB balances, and significant unremitted foreign earnings. Post-TCJA, pay attention to GILTI and BEAT provisions that affect multinational tax structures. Compare the cash taxes paid (from the cash flow statement) against the income tax provision to gauge earnings quality.